Recombinant human hyaluronidase facilitated subcutaneous immunoglobulin treatment in pediatric patients with primary immunodeficiencies: long-term efficacy, safety and tolerability.

Details

Language :

English

ISSN :

1750743X

Volume :

8

Issue :

10

Database :

Complementary Index

Journal :

Immunotherapy (1750743X)

Publication Type :

Academic Journal

Accession number :

118058779

Full Text :

https://doi.org/10.2217/imt-2016-0066